Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram.

Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram.

Item

http://www.wikidata.org/entity/Q33897936

Q33897936

about

SB 206553, a putative 5-HT2C inverse agonist, attenuates methamphetamine-seeking in rats Tricyclic antidepressant pharmacology and therapeutic drug interactions updated Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs New onset multimodal hallucinations associated with mirtazapine: a case report.Inhibition of stress- or anxiogenic-drug-induced increases in dopamine release in the rat prefrontal cortex by long-term treatment with antidepressant drugs.Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders.Mirtazapine alters cue-associated methamphetamine seeking in rats Could agomelatine be the ideal antidepressant?Differential mechanisms underlie the regulation of serotonergic transmission in the dorsal and median raphe nuclei by mirtazapine: a dual probe microdialysis study.On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons?Reversal of long-term methamphetamine sensitization by combination of pergolide with ondansetron or ketanserin, but not mirtazapine.New approaches to developing antidepressants by enhancing monoaminergic neurotransmission.Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance Mirtazapine provokes periodic leg movements during sleep in young healthy men.Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.Circuits Regulating Pleasure and Happiness-Mechanisms of Depression.Improving antidepressant drugs: update on recently patented compounds.Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.Adjunct mirtazapine for negative symptoms of schizophrenia.Role of melatonin in mood disorders and the antidepressant effects of agomelatine.Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.Agomelatine in depression.α2-Adrenoceptors are targets for antipsychotic drugs.Efficacy of adjunctive aripiprazole in major depressive disorder: a pooled response quartile analysis and the predictive value of week 2 early response.Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.Suppression of metastasis by mirtazapine via restoration of the Lin-7C/β-catenin pathway in human cancer cells PET kinetics of radiolabeled antidepressant, [N-methyl-11C]mirtazapine, in the human brain.Effect of the coadministration of citalopram with mirtazapine or atipamezole on rat contextual conditioned fear.Selective serotonin reuptake blockade increases extracellular dopamine in noradrenaline-rich isocortical but not prefrontal areas: dependence on serotonin-1A receptors and independence from noradrenergic innervation.Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats.Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.Chronic treatment with imipramine or mirtazapine antagonizes stress- and FG7142-induced increase in cortical norepinephrine output in freely moving rats.Regulation of platelet alpha 2A-adrenoceptors, Gi proteins and receptor kinases in major depression: effects of mirtazapine treatment.The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex.Involvement of serotonin 5-HT3 receptors in the modulation of noradrenergic transmission by serotonin reuptake inhibitors: a microdialysis study in rat brain.Mirtazapine, a noradrenergic and specific serotonergic antidepressant, attenuates morphine dependence and withdrawal in Sprague-Dawley rats.Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus.Effects of 5-HT1A, 5-HT2A and 5-HT2C receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate.

P2860

Q21262960-5A2C21EA-41F2-42B0-8C05-C9CDA31D036F Q24564967-1E7163B5-BF93-459A-A2E4-A92100394EA3 Q24806184-7E3121C8-D75F-4962-B2CA-49C5B4761891 Q28305100-FEA15834-BF1B-4BF7-A67F-58E7179F9697 Q30548818-781B6A7E-6BFE-4AC4-8F66-EE76491CDD3E Q31962157-2B548387-9B35-4BA0-9E23-374A50AAC2D9 Q34177643-F2F7ECD6-FEBC-4A59-AFEC-A61B9FCB454A Q34462084-36946A40-7BDD-4678-BC72-A0B01632FE04 Q34572999-EA96984F-E840-4D26-8045-A32F7D90AB04 Q34661038-2BC51660-02B5-4243-B202-B4C9F2B69B34 Q34794235-A0071CCB-C452-4266-8BA6-BA44A8A8CD41 Q35040501-88B6AE7D-F6A8-4855-B4C9-EF612174046F Q35094650-D74EF2BB-F55A-46B5-91CA-BC4C75DC3564 Q36067334-9581F7BE-214F-4992-9D68-F794CCE46EF2 Q36761266-0C35C1C4-D0E1-47BA-BC2F-26B15108A626 Q37307331-9C4D8848-B051-4589-88DD-FC3C9743500C Q37405040-6C7AB59C-30E9-4790-BC4B-5EF544CA12E3 Q37497379-1CB92429-D22F-478C-A950-E440DE701ADF Q37734565-7A0C6EEB-9B2C-4289-B96C-CF241D2DB16E Q37939248-447C26B7-3219-4C25-83C3-5494871777A1 Q38033191-F63B0DDA-5986-4C7F-A8D9-A118F8E6C56F Q38101499-CB96DDBA-9C47-4651-AD30-31405FF96FF6 Q38137187-CA2F38CC-FB8B-4D2F-B59D-F6E5472CDA76 Q38184439-7BA9CCF1-D8F7-4E4C-A414-57C9065F0F29 Q38462018-D39CA8B9-16CA-48EF-B987-64058E64FC1C Q38647035-0147C70B-078F-46F6-B015-0EDC137242BA Q38981661-AA7A1CBB-CE66-49DF-9674-1D0941EC55CD Q40498912-97E8ADBA-AAB9-4723-AA27-B60835C52FBF Q41971497-9B348545-51DA-4A14-83C2-038076695F1C Q42476634-610A4420-A383-4D23-B7B0-30E0225151E3 Q43548242-107A191E-43FE-439B-A638-232A26235C33 Q43775304-C35F54D8-7A58-4B8E-873B-152C5D5EAA0F Q43825642-B6D86329-49CA-4E0D-A458-FF6F6C37672F Q44662313-2A06CFC2-3680-4AF8-96D1-8B4498E485CB Q45053008-A63B1E61-FFD9-4AD3-A91B-F578C30B1D2F Q45233014-E02F2A66-4C6E-4831-A52C-1A89CD1049D5 Q45242499-94C59C27-E8CD-4EA5-B348-0EFE609D22FE Q46489870-213C4B28-E920-44FB-BCFD-21128C2C91A2 Q46640346-A1466302-90D6-408B-AE16-6EDC2257D6A0 Q47825190-CA5AA0E7-2056-43F7-8F19-83B8EB57D3D5

P2860

Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram.

Item

http://www.wikidata.org/entity/Q33897936

description

2000 nî lūn-bûn

@nan

2000 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի մարտին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu